ID   NZM103
AC   CVCL_0D62
DR   cancercelllines; CVCL_0D62
DR   Wikidata; Q54931523
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 13,18
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,9
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran, Khanh B.
RA   Gimenez, Gregory
RA   Tsai, Peter
RA   Kolekar, Sharada
RA   Rodger, Euan J.
RA   Chatterjee, Aniruddha
RA   Jabed, Anower
RA   Shih, Jen-Hsing
RA   Joseph, Wayne R.
RA   Marshall, Elaine S.
RA   Wang, Qian
RA   Print, Cristin Gregor
RA   Eccles, Michael R.
RA   Baguley, Bruce Charles
RA   Shepherd, Peter R.
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//